From: Cervical Cancer Treatment (PDQ®)
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Table 7. Drugs Used to Treat Recurrent Cervical Cancer
| Drug Name | Response Rate |
|---|---|
| Cisplatin [7] | 15%–25% |
| Ifosfamide [8,9] | 15%–30% |
| Paclitaxel [10] | 17% |
| Irinotecan [11] | 21% in patients previously treated with chemotherapy |
| Bevacizumab [12] | 11%; 24% survived progression free for at least 6 months, as seen in GOG-0227C (NCT00025233) |
| Ifosfamide/cisplatin [13,14] | 31% |
| Paclitaxel/cisplatin [15] | 46% |
| Cisplatin/gemcitabine [16] | 41% |
| Cisplatin/topotecan [17] | 27% |
| Cisplatin/vinorelbine [18] | 30% |